Page last updated: 2024-10-21

ethylisopropylamiloride and Ischemic Attack, Transient

ethylisopropylamiloride has been researched along with Ischemic Attack, Transient in 1 studies

ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, IK1
Yoo, KY1
An, SJ1
Li, H1
Lee, CH1
Choi, JH1
Lee, JY1
Lee, BH1
Kim, YM1
Kwon, YG1
Won, MH1

Other Studies

1 other study available for ethylisopropylamiloride and Ischemic Attack, Transient

ArticleYear
Late expression of Na+/H+ exchanger 1 (NHE1) and neuroprotective effects of NHE inhibitor in the gerbil hippocampal CA1 region induced by transient ischemia.
    Experimental neurology, 2008, Volume: 212, Issue:2

    Topics: Amiloride; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gen

2008